Skip to content
10-Q

Quarterly Report

Treace Medical Concepts, Inc. TMCI

0000950170-25-105059

← back to feed
Filed
Aug 7, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Jul 31, 2025 63.17M sh
Shares Diluted Q2 2025 · Jun 30, 2025 63.01M sh
Shares Diluted Q2 2025 · Jun 30, 2025 62.84M sh
Shares Diluted Q2 2025 · Jun 30, 2024 62.08M sh
Shares Diluted Q2 2025 · Jun 30, 2024 61.94M sh
Capex Q2 2025 · Jun 30, 2025 $8.31M
Capex Q2 2025 · Jun 30, 2024 $5.66M
Operating Cash Flow Q2 2025 · Jun 30, 2025 $1.15M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$21.12M
Long Term Debt Q2 2025 · Jun 30, 2025 $53.45M
Long Term Debt Q2 2025 · Dec 31, 2024 $53.31M
Short Term Debt Q2 2025 · Jun 30, 2025 $1.11M
Short Term Debt Q2 2025 · Dec 31, 2024 $0
Cash And Equivalents Q2 2025 · Jun 30, 2025 $8.05M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $11.35M
Stockholders Equity Q2 2025 · Jun 30, 2025 $97.62M
Stockholders Equity Q2 2025 · Mar 31, 2025 $105.34M
Stockholders Equity Q2 2025 · Dec 31, 2024 $112.89M
Stockholders Equity Q2 2025 · Jun 30, 2024 $112.14M
Stockholders Equity Q2 2025 · Mar 31, 2024 $126.39M
Stockholders Equity Q2 2025 · Dec 31, 2023 $137.94M
Current Liabilities Q2 2025 · Jun 30, 2025 $41.9M
Current Liabilities Q2 2025 · Dec 31, 2024 $34.93M
Total Liabilities Q2 2025 · Jun 30, 2025 $108.83M
Total Liabilities Q2 2025 · Dec 31, 2024 $104.2M
Current Assets Q2 2025 · Jun 30, 2025 $147.6M
Current Assets Q2 2025 · Dec 31, 2024 $161.4M
Total Assets Q2 2025 · Jun 30, 2025 $206.44M
Total Assets Q2 2025 · Dec 31, 2024 $217.09M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.28
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.53
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.34
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.64
Eps Basic Q2 2025 · Jun 30, 2025 −$0.28
Eps Basic Q2 2025 · Jun 30, 2025 −$0.53
Eps Basic Q2 2025 · Jun 30, 2024 −$0.34
Eps Basic Q2 2025 · Jun 30, 2024 −$0.64
Sga Expense Q2 2025 · Jun 30, 2025 $16.14M
Sga Expense Q2 2025 · Jun 30, 2025 $31.94M
Sga Expense Q2 2025 · Jun 30, 2024 $14.22M
Sga Expense Q2 2025 · Jun 30, 2024 $28.58M
Rd Expense Q2 2025 · Jun 30, 2025 $5.5M
Rd Expense Q2 2025 · Jun 30, 2025 $11.06M
Rd Expense Q2 2025 · Jun 30, 2024 $5.16M
Rd Expense Q2 2025 · Jun 30, 2024 $10.42M
Net Income Q2 2025 · Jun 30, 2025 −$17.4M
Net Income Q2 2025 · Jun 30, 2025 −$33.32M
Net Income Q2 2025 · Mar 31, 2025 −$15.92M
Net Income Q2 2025 · Jun 30, 2024 −$21.21M
Net Income Q2 2025 · Jun 30, 2024 −$39.88M
Net Income Q2 2025 · Mar 31, 2024 −$18.68M
Operating Income Q2 2025 · Jun 30, 2025 −$16.97M
Operating Income Q2 2025 · Jun 30, 2025 −$32.56M
Operating Income Q2 2025 · Jun 30, 2024 −$21.38M
Operating Income Q2 2025 · Jun 30, 2024 −$40.35M
Gross Profit Q2 2025 · Jun 30, 2025 $37.75M
Gross Profit Q2 2025 · Jun 30, 2025 $79.65M
Gross Profit Q2 2025 · Jun 30, 2024 $35.67M
Gross Profit Q2 2025 · Jun 30, 2024 $76.66M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $9.64M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $20.31M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $8.78M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $18.91M
Revenue Q2 2025 · Jun 30, 2025 $47.39M
Revenue Q2 2025 · Jun 30, 2025 $99.96M
Revenue Q2 2025 · Jun 30, 2024 $44.46M
Revenue Q2 2025 · Jun 30, 2024 $95.56M